Drug Target Review2024-03-07T12:00:20
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-05T13:24:00
Sponsored by HUB Organoids
2026-06-24T13:00:00
Sponsored by HUB Organoids
2026-09-23T15:00:00
Sponsored by BioIVT
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-09-27T13:56:39
Sponsored by Euretos
2025-09-18T12:00:00
Sponsored by Benchling
Site powered by Webvision Cloud